US Patent Issued to Windtree Therapeutics on July 1 for "Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)" (Italian Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,350, issued on July 1, was assigned to Windtree Therapeutics Inc. (Warrington, Pa.).

"Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)" was invented by Giuseppe Bianchi (Milan), Patrizia Ferrari (Varese, Italy), Mara Ferrandi (Milan) and Paolo Barassi (Castelveccana, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions for intravenous infusion of istaroxime, or a metabolite of istaroxime, in human patients suffering from heart failure are disclosed. Likewise, methods for extended infusion of istaroxime or its metabolites in individuals with heart failure are disclosed. In particular, some metho...